Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin in Functional Dyspepsia
NCT01643083Phase 3Completed
- Sponsor
- The University of Hong Kong
- Start
- Jan 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifaximin in functional dyspepsia (FD), sponsored by The University of Hong Kong. Started Jan 2013; status: completed.
02
Drugs
rifaximin
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT01643083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01643083.